Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype

Mutations in leucine‐rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease (PD). The LRRK2 physiological and pathological function is still debated. However, different experimental evidence based on LRRK2 cellular localization and LRRK2 protein interactors sugges...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Cell Mol Med
Main Authors: Rassu, Mauro, Biosa, Alice, Galioto, Manuela, Fais, Milena, Sini, Paola, Greggio, Elisa, Piccoli, Giovanni, Crosio, Claudia, Iaccarino, Ciro
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2019
Teme:
Short Communications
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850958/
https://ncbi.nlm.nih.gov/pubmed/31560168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14674
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki